FOR IMMEDIATE RELEASE

NOTICE OF PALADIN LABS INC. CONFERENCE CALL

Montreal, Canada, October 28, 2002 - Paladin Labs Inc. (TSX: PLB) will host a conference call to discuss its 2002 third quarter results on Thursday, October 31, 2002, at 10:00 a.m. (EST). Paladin cordially invites all interested parties to participate in this call.

DATE:	Thursday, October 31, 2002
TIME:	10:00 a.m. EST
DIAL IN NUMBER:	1-800-273-9672 or 416-695-5806
REFERENCE NUMBER:	1298925
TAPED REPLAY:	1-800-408-3053 OR 416-695-5800 Available from Thursday, October 31st at noon until Thursday, November 7th at midnight.

The call will be hosted by Mr. Jonathan Ross Goodman, President and CEO of Paladin Labs. There will be a question and answer period following management's presentation. The Company looks forward to your participation.

The call will also be audio-cast live and archived for 90 days at www.paladinlabs.com and www.financialdisclosure.ca.

About Paladin Labs Inc.
Paladin Labs Inc., headquartered in Montreal, Quebec, is a rapidly growing pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's most profitable publicly-traded pharmaceutical companies. Paladin's shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Paladin Web Site at www.paladinlabs.com

For further information please contact:

Paladin Labs Inc.
Samira Sakhia, Chief Financial Officer
Tel: 514-340-5067
e-mail: info@paladin-labs.com
Web Site: www.paladinlabs.com

The Equicom Group Inc.
Bruce Wigle
Investor Relations
Tel: 416-815-0700 ext.228
e-mail: bwigle@equicomgroup.com